effects [qlco]
weeks [tmco]
Novel [tmco]
Estrogen receptor [aapp, rcpt]
Modulator [mnob]
Marker [clna]
Coagulation [ortf]
Fibrinolysis [phsf]
randomized [resa]
placebo controlled study [inpr, resa]
DOUBLE BLIND [resa]
Dose [qnco]
Range [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
To [qlco]
investigate [ftcn]
Short-term [tmco]
effects [qlco]
Novel [tmco]
Selective Estrogen Receptor Modulator [horm, phsu]
Marker [clna]
Coagulation [ortf]
Fibrinolysis [phsf]
Study Design [resa]
randomized [resa]
placebo-controlled [resa]
DOUBLE BLIND [resa]
Dose [qnco]
Range [qnco]
Study [mnob]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
Daily [tmco]
placebo [topp]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
N NOS [aapp, imft]
statistical analysis [resa]
Performed [ftcn]
Using [ftcn]
Standard [qlco]
Parametric Test [inpr]
Result [ftcn]
weeks [tmco]
Compared [acty]
placebo [topp]
mg% [qnco]
Induced [ftcn]
Largest [qnco]
Mean [qnco]
Percentage [qnco]
Change [ftcn]
Antithrombin [aapp, phsu]
P NOS [aapp, imft]
Protein C [aapp, bacs, phsu]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
decreases [qnco]
Observed [ftcn]
mg% [qnco]
Group [idcn]
Compared [acty]
placebo [topp]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
P NOS [aapp, imft]
Plasmin [aapp, enzy, phsu]
Complex [qlco]
P NOS [aapp, imft]
P NOS [aapp, imft]
weeks [tmco]
D-dimer [aapp, bacs]
P NOS [aapp, imft]
weeks [tmco]
Compared [acty]
placebo [topp]
Decreased [qnco]
Total protein [lbpr]
P NOS [aapp, imft]
Antithrombin [aapp, phsu]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
weeks [tmco]
Conclusion [idcn]
Raloxifene [orch, phsu]
Decreased fibrinogen [fndg]
Levels [qlco]
low [qlco]
Dosage [qnco]
Show [inpr]
effects [qlco]
Marker [clna]
Fibrinolysis [phsf]
Drugs [phsu]
Impaired [ftcn]
Potential [qlco]
[c] [qnco]
Rights [qlco]
Reserve [acty]
